Moderna, Inc., on Wednesday announced the finalization of a strategic partnership with the Australian Federal Government to establish a state-of-the-art, domestic mRNA vaccine manufacturing...
Novartis announced today that the US Food and Drug Administration (FDA) approved Pluvicto™(lutetium Lu 177 vipivotide tetraxetan) for the treatment of adult patients with...
Sandoz Inc has persuaded a Delaware federal judge to throw out a lawsuit that claimed its proposed generic version of a blockbuster lung-disease drug...
Recro Pharma, Inc. (“Recro”), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges primarily in small molecule therapeutic...
Moderna, Inc., today announced positive interim data from the Phase 2/3 KidCOVE study of the Moderna COVID-19 vaccine (mRNA-1273) in children 6 months to...
An inspection at the Abbott Laboratories facility in Sturgis, Michigan found harmful bacteria on surfaces in some areas of its powdered baby formula production,...